Subsequently, these authors applied a systems biology mathematical model that simulates NAFLD pathophysiology concluding that RUNX1 has a high relationship with hepatic injury-liver fibrosis, and a medium relationship with lipotoxicity and insulin resistance [192]. Here, RUNX1 is linked to metabolic dysfunction-associated steatotic liver disease.